As medical technologies evolve at lightning speed – integrating artificial intelligence, wearable tech, and patient-directed innovations – regulatory agencies worldwide are working to keep pace. Thailand is no exception. Over the past decade, the country has introduced reforms to its medical device regulatory framework to safeguard public health while promoting innovation and getting the best treatments for Thai citizens. If you’re looking to register a medical device in Thailand, understanding the evolving regulatory landscape is essential.
Overview of the Regulatory Authority
In Thailand, medical device regulation falls under the jurisdiction of the Medical Device Control Division (MDCD), part of the Thai Food and Drug Administration (TFDA), which operates under the Ministry of Public Health (MoPH). All manufacturers, importers, and sellers must comply with the requirements set out by the TFDA and the MDCD before conducting any medical device business.
Legislative Evolution: From Drugs to Devices
Before 1988, medical devices were regulated under the Drug Act of 1967, a framework deemed ill-suited for modern device technologies. This changed with the enactment of the Medical Device Act B.E. 2531 (1988), and later the amended Act B.E. 2551 (2008), which introduced clearer distinctions between drugs and devices and established the MDCD.
Today, the regulatory framework consists of this amended Act, along with a series of Notifications and Ministerial Regulations issued by the MoPH and TFDA.
Definition of a Medical Device
Thailand’s definition of a medical device aligns closely with international norms. According to the Medical Device Act, a medical device may include instruments, machines, implants, reagents, software, or accessories used for:
- Diagnosis, monitoring, or treatment of human or animal diseases
- Physiological support or anatomical modification
- Contraception or fertility enhancement
- In vitro testing of biological specimens
- Disinfection or sterilization of devices
Importantly, the mechanism of action for these devices must not be pharmacological, immunological, or metabolic.
Medical Device Classification in Thailand
Thailand employs a unique, multi-tiered classification system that incorporates both national priorities and ASEAN harmonization efforts.
ASEAN Risk-Based Classification
Under the ASEAN Medical Device Directive (AMDD), which Thailand has committed to implementing, devices are classified into four risk-based categories:
- Class A: Low risk
- Class B: Low-moderate risk
- Class C: Moderate-high risk
- Class D: High risk
This classification system aligns closely with the EU and other international frameworks.
Clinical Trial Oversight
Although clinical studies are not mandatory for device registration, if needed, clinical trials must follow ICH-GCP standards and be approved by a hospital ethics committee. The TFDA indirectly supervises trials by controlling the importation of investigational devices.
The Registration Process
- Engage a Local Authorized Representative
Foreign manufacturers cannot register devices directly in Thailand. A locally established company must serve as the official registrant, importer, and local agent. This representative is responsible for submitting the application and serving as the contact point for the Thai Food and Drug Administration (TFDA).
- Determine Classification
Accurate classification is essential. In borderline cases – e.g., devices that might also be classified as drugs, such as dermal fillers – the TFDA may require additional documents and expert committee review, which can extend the review timeline by several months.
- Prepare and Compile the Required Documents
The level of documentation depends on your device’s classification. However, certain core materials are typically required:
- CSDT (Common Submission Dossier Template) including:
- Executive Summary
- Essential Principles and Evidence of Conformity
- Device Description and Product Verification
- Manufacturing Information
- Clinical Evidence (if needed)
- Risk Analysis
- Certificate of Free Sale (CFS) from the country of origin
- ISO 13485 certificate (for implantable, sterile, or laser devices)
- Labeling and Instructions for Use (IFU) in Thai or bilingual format
- Product brochures or catalogs
- Letter of Authorization from the foreign manufacturer (for importers)
- Post-Approval Obligations
Approved licenses are valid for five years. Companies must also comply with vigilance and post-market surveillance obligations.
Recent Update: Streamlined Registration
On April 29, 2024, the Thai FDA introduced updated guidelines to simplify medical device registration, effective immediately upon publication in the Royal Gazette. The revisions aim to accelerate approvals by reducing documentation requirements, particularly for devices already approved in major international markets.
- Full Evaluations no longer require:
- Intended use certification letters
- Marketing history
- Safety declarations
- Foreign approval verification
- Concise Evaluations (for devices having been approved for at least one year by at least one of the major agencies, such as the US FDA, EU Notified Bodies, or Health Canada) are exempt from:
- Design verification
- Risk analysis
- Waste disposal documentation
This applies only if the device’s trade name, intended use, labeling, and packaging remain unchanged. However, the Thai FDA may still request additional documents if concerns arise, maintaining regulatory oversight while facilitating faster market access.
Building on these reforms, the Thai FDA implemented a new auto-approval process for Class 1 medical devices on January 15, 2025. This process is designed to significantly shorten the registration timeline for low-risk products. Manufacturers must still submit the required data and pay the associated fees, but once these are received, a registration number is issued automatically without waiting for manual review. The Thai FDA maintains a “Positive List” of Class 1 devices that qualify for this fast-track process. This list, which is regularly updated, currently includes products such as dental mirrors, electrodes, and eye patches.
These changes offer a more efficient path for globally approved devices to enter the Thai market, which reduces administrative burden without compromising safety.
Post-Market Surveillance
All companies must maintain sales and distribution records for a minimum of five years. The TFDA conducts regular inspections and sampling to monitor compliance, and violations may lead to fines, imprisonment, or both. The TFDA also monitors advertising content and labeling for accuracy.
Medical device companies are legally required to report serious defects or adverse events to the TFDA under a strict timeline:
- Immediate or within 48 hours: Serious threat to public health
- Within 10 days: Events leading to death or life-threatening situations
- Within 30 days: Events that could lead to serious harm or death upon recurrence
Reports must be submitted using the Field Safety Corrective Action (FSCA) form to the TFDA’s Health Product Vigilance Centre (HPVC), either online or in person.
Conclusion
Companies aiming to enter the Thai market must be proactive in understanding classification, assembling high-quality dossiers, and preparing for both pre- and post-market obligations. Partnering with a knowledgeable local representative and staying updated on the implementation of new laws will be key to successful market entry and long-term compliance.
Written by: Ames Gross – President and Founder, Pacific Bridge Medical (PBM)
Mr. Gross founded PBM in 1988 and has helped hundreds of medical companies with regulatory and business development issues in Asia. He is recognized nationally and internationally as a leader in the Asian medical markets. Mr. Gross has a BA degree, Phi Beta Kappa, from the University of Pennsylvania and an MBA from Columbia University.